BRIVZO
Live / Applied — Second extension granted (statement of use) (as of 12 Aug 2025)
What this means for you
Not registered yet, but its 18 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98184162
- Mark type
- Stylized text
- Filed
- 18 Sept 2023
- Published for opposition
- 16 Jul 2024
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: intravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions
- Class 010 — Medical apparatus: Medical device, namely, intraocular implant
Owner
- Neurotech Pharmaceuticals, Inc., Cumberland, RI, US
- Neurotech Pharmaceuticals, Inc., Cumberland, RI, US
Prosecution history
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 2 GRANTED
- 12 Aug 2025 — SOU EXTENSION 2 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2025 — SOU EXTENSION 1 GRANTED
- 11 Feb 2025 — SOU EXTENSION 1 FILED
- 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 16 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jul 2024 — PUBLISHED FOR OPPOSITION
- 26 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER